comprehensive -WSS

comprehensive

author：knowledge 2025-09-30 14:08:44 - browse：6873

om DiLenge (CQ in grey suit ) Flagship Pioneering Cambridge with US Congressman Raja Krishnamoorthi of Illinois were talking together at the event. Biotech companies demonstrating their medicines and materials at a "tech fair" designed to showcase the need to compete with Chinese biotech held at Harvard Kennedy School in Cambridge. The growing US backlash against the perceived national security threat posed by China's rising biotech industry — Tom DiLenge of Flagship Pioneering (left) with U.S. Congressman Raja Krishnamoorthi of Illinois at a "tech fair" designed to showcase the need to compete with Chinese biotech held at Harvard Kennedy School in Cambridge, Mass. David L Ryan/The Boston Globe

CAMBRIDGE, Mass. — The increasingly adversarial relationship between the United States and China has raised national security concerns about Chinese penetration into key sectors of the U.S. economy, such as technology, manufacturing, and clean energy.

Now, some in Congress are raising alarms about China’s threat to another vital industry: biotechnology.

A bipartisan group of lawmakers visited Massachusetts this week to call attention to that threat and call for strengthening U.S. life sciences companies, protecting their technologies, and safeguarding Americans’ genetic data from a Chinese biotech industry with close ties to the authoritarian state.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Activists slam private health insurers over coverage restrictions
Next article： What causes rare myocarditis in young men after Covid vaccines?

Wikipedia

WSS

Christmas in the PICU brings some surprising joy

Carvykti CAR

CDC Director Mandy Cohen on transparency, trust, and health

US economic growth accelerated in 2nd quarter, exceeding expectations and quieting recession fears

CRISPR gene editing developments we’re watching in 2024

Can sheer will power keep patients alive in their dying hours?

leisure time

comprehensive

focus

The cancer drug shortage isn’t new — and neither are the solutions

Bristol Myers buys into radiopharmaceuticals with RayzeBio

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Will the FTC rein in IQVIA's health data empire?

Moonlake's readout produced a cash windfall. Risks remain

In Spain, a hospital brews its own CAR

Sports medicine is finally prioritizing gender equality

Drinking less cuts risk of oral cavity, esophageal cancer: Report

What does generative AI mean for health care? We asked experts

Device maker Teleflex to acquire urology company for $600M

focus

Virtual care provider acquires bankrupt Pear's prescription apps

CDC Director Mandy Cohen on transparency, trust, and health

Bristol Myers buys into radiopharmaceuticals with RayzeBio

Device maker Teleflex to acquire urology company for $600M

CDC Director Mandy Cohen on transparency, trust, and health

Editas, Vertex strike deal on CRISPR

hotspot

Wikipedia

Wikipedia

knowledge